RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.1023%2Fa%3A1008360323986
https://w3id.org/ripe/ripe-kg/work/10.1023%2Fa%3A1008360323986
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1023%2Fa%3A1008360323986Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group |
prism:doi |
10.1023/a:1008360323986 |
ripekg:work/10.1023%2Fa%3A1008360323986Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group |
dcterms:title |
Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group |
ripekg:work/10.1023%2Fa%3A1008360323986Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group |
rdf:type |
node1 |
ripekg:work/10.1023%2Fa%3A1008360323986Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1023%2Fa%3A1008360323986Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group |
rdf:type |
rdfs:Resource |
ripekg:work/10.1023%2Fa%3A1008360323986Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group |
rdf:type |
owl:Thing |
ripekg:work/10.1023%2Fa%3A1008360323986Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group |
rdf:type |
prov:Entity |
ripekg:work/10.1023%2Fa%3A1008360323986Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1023%2Fa%3A1008360323986Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group |
owl:sameAs |
https://semopenalex.org/work/W2145115983 |
ripekg:work/10.1136%2Fbmj-2024-081557Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/10.1023%2Fa%3A1008360323986Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group |